Purpose: Lung cancer screening (LCS) by low-dose computed tomography (LDCT) demonstrated a 20–40% reduction in lung cancer mortality. National stakeholders and international scientific societies are increasingly endorsing LCS programs, but translating their benefits into practice is rather challenging. The “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth” (PEOPLHE) is an Italian multicentric LCS program aiming at testing LCS feasibility and implementation within the national healthcare system. PEOPLHE is intended to assess (i) strategies to optimize LCS workflow, (ii) radiological quality assurance, and (iii) the need for dedicated resources, including smoking cessation facilities. Methods: PEOPLHE aims to recruit 1.500 high-risk individuals across three tertiary general hospitals in three different Italian regions that provide comprehensive services to large populations to explore geographic, demographic, and socioeconomic diversities. Screening by LDCT will target current or former (quitting < 10 years) smokers (> 15 cigarettes/day for > 25 years, or > 10 cigarettes/day for > 30 years) aged 50–75 years. Lung nodules will be volumetric measured and classified by a modified PEOPLHE Lung-RADS 1.1 system. Current smokers will be offered smoking cessation support. Conclusion: The PEOPLHE program will provide information on strategies for screening enrollment and smoking cessation interventions; administrative, organizational, and radiological needs for performing a state-of-the-art LCS; collateral and incidental findings (both pulmonary and extrapulmonary), contributing to the LCS implementation within national healthcare systems.
Study rationale and design of the PEOPLHE trial / Milanese, G.; Silva, M.; Ledda, R. E.; Iezzi, E.; Bortolotto, C.; Mauro, L. A.; Valentini, A.; Reali, L.; Bottinelli, O. M.; Ilardi, A.; Basile, A.; Palmucci, S.; Preda, L.; Sverzellati, N.; Aliotta, L.; Barbarino, S.; Borzi, S.; Casotto, V.; Catalano, M.; Cavalieri, D. M.; Clemenza, M.; Contino, M.; Crimi, L.; Curia, B.; Favia, P.; Gallone, V. I.; Guicciardi, G.; La Rosa, G.; Leo, L.; Mura, R.; Priore, A.; Ruongo, L.; Scavone, C.; Zilioli, C.. - In: LA RADIOLOGIA MEDICA. - ISSN 0033-8362. - 129:3(2024), pp. 411-419. [10.1007/s11547-024-01764-4]
Study rationale and design of the PEOPLHE trial
Milanese G.Investigation
;Silva M.Investigation
;Ledda R. E.Investigation
;Sverzellati N.
Investigation
;Cavalieri D. M.Data Curation
;Favia P.Data Curation
;Gallone V. I.Data Curation
;Leo L.Formal Analysis
;Mura R.Data Curation
;Zilioli C.Data Curation
2024-01-01
Abstract
Purpose: Lung cancer screening (LCS) by low-dose computed tomography (LDCT) demonstrated a 20–40% reduction in lung cancer mortality. National stakeholders and international scientific societies are increasingly endorsing LCS programs, but translating their benefits into practice is rather challenging. The “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth” (PEOPLHE) is an Italian multicentric LCS program aiming at testing LCS feasibility and implementation within the national healthcare system. PEOPLHE is intended to assess (i) strategies to optimize LCS workflow, (ii) radiological quality assurance, and (iii) the need for dedicated resources, including smoking cessation facilities. Methods: PEOPLHE aims to recruit 1.500 high-risk individuals across three tertiary general hospitals in three different Italian regions that provide comprehensive services to large populations to explore geographic, demographic, and socioeconomic diversities. Screening by LDCT will target current or former (quitting < 10 years) smokers (> 15 cigarettes/day for > 25 years, or > 10 cigarettes/day for > 30 years) aged 50–75 years. Lung nodules will be volumetric measured and classified by a modified PEOPLHE Lung-RADS 1.1 system. Current smokers will be offered smoking cessation support. Conclusion: The PEOPLHE program will provide information on strategies for screening enrollment and smoking cessation interventions; administrative, organizational, and radiological needs for performing a state-of-the-art LCS; collateral and incidental findings (both pulmonary and extrapulmonary), contributing to the LCS implementation within national healthcare systems.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.